ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,032 | -74.5% | 11,970 | 0.0% | 0.00% | – |
Q4 2022 | $74,573 | +113.1% | 11,970 | +307.0% | 0.00% | – |
Q3 2021 | $35,000 | -43.5% | 2,941 | 0.0% | 0.00% | – |
Q2 2021 | $62,000 | -24.4% | 2,941 | 0.0% | 0.00% | – |
Q1 2021 | $82,000 | +7.9% | 2,941 | 0.0% | 0.00% | – |
Q4 2020 | $76,000 | -30.3% | 2,941 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $109,000 | -27.8% | 2,941 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $151,000 | +122.1% | 2,941 | +36.2% | 0.00% | 0.0% |
Q1 2020 | $68,000 | -16.0% | 2,159 | +59.8% | 0.00% | 0.0% |
Q4 2019 | $81,000 | +62.0% | 1,351 | 0.0% | 0.00% | – |
Q3 2019 | $50,000 | -20.6% | 1,351 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $63,000 | +16.7% | 1,351 | 0.0% | 0.00% | – |
Q1 2019 | $54,000 | -12.9% | 1,351 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $62,000 | +3.3% | 1,351 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $60,000 | +30.4% | 1,351 | +15.7% | 0.00% | – |
Q2 2018 | $46,000 | -45.2% | 1,168 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $84,000 | +9.1% | 1,168 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $77,000 | +92.5% | 1,168 | +47.1% | 0.00% | – |
Q3 2017 | $40,000 | +73.9% | 794 | +56.9% | 0.00% | – |
Q2 2017 | $23,000 | +27.8% | 506 | 0.0% | 0.00% | – |
Q1 2017 | $18,000 | +200.0% | 506 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | -14.3% | 506 | 0.0% | 0.00% | – |
Q3 2016 | $7,000 | +40.0% | 506 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | -44.4% | 506 | 0.0% | 0.00% | – |
Q1 2016 | $9,000 | -18.2% | 506 | 0.0% | 0.00% | – |
Q4 2015 | $11,000 | +120.0% | 506 | +122.9% | 0.00% | – |
Q3 2015 | $5,000 | -61.5% | 227 | +39.3% | 0.00% | – |
Q2 2015 | $13,000 | +44.4% | 163 | +63.0% | 0.00% | – |
Q1 2015 | $9,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |